These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. Horký K Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167 [TBL] [Abstract][Full Text] [Related]
47. Rethinking heart rate : and new horizons in treating it. Cardiovasc J Afr; 2008; 19(2):114-5. PubMed ID: 18516360 [No Abstract] [Full Text] [Related]
48. Role of the natriuretic peptide system in cardiorenal protection. McFarlane SI; Winer N; Sowers JR Arch Intern Med; 2003 Dec 8-22; 163(22):2696-704. PubMed ID: 14662623 [TBL] [Abstract][Full Text] [Related]
49. [Left ventricular diastolic function: physiological and pathophysiological significance]. Hess OM; Krayenbühl HP Schweiz Rundsch Med Prax; 1988 Jun; 77(24):685-9. PubMed ID: 3399766 [No Abstract] [Full Text] [Related]
50. [The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies]. Cittadini A; Durante Mangoni E; Palmieri EA; Casaburi C; Longobardi S; Di Rella F; Fazio S; Saccà L Cardiologia; 1998 Nov; 43(11):1185-92. PubMed ID: 9922584 [No Abstract] [Full Text] [Related]
54. Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. Wong LS; Oeseburg H; de Boer RA; van Gilst WH; van Veldhuisen DJ; van der Harst P Cardiovasc Res; 2009 Feb; 81(2):244-52. PubMed ID: 19047341 [TBL] [Abstract][Full Text] [Related]
55. Telomeres and cardiovascular disease: does size matter? Serrano AL; Andrés V Circ Res; 2004 Mar; 94(5):575-84. PubMed ID: 15031270 [TBL] [Abstract][Full Text] [Related]